A61K 2039/6093
Synthetic polymers
Official title: {Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine}
A61K2039/6093 (Synthetic polymers) appears on 309 US grants and 515 published applications in this corpus.
Search patents in A61K- Granted patents
- 309
- Published applications
- 515
- Assignees
- 246
- Inventors
- 955
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 3 | 0 |
| 1980 | 4 | 0 |
| 1981 | 6 | 0 |
| 1982 | 0 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 4 | 0 |
| 1999 | 7 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 1 |
| 2002 | 4 | 9 |
| 2003 | 4 | 9 |
| 2004 | 0 | 10 |
| 2005 | 2 | 9 |
| 2006 | 4 | 6 |
| 2007 | 3 | 11 |
| 2008 | 2 | 14 |
| 2009 | 6 | 12 |
| 2010 | 6 | 15 |
| 2011 | 10 | 18 |
| 2012 | 5 | 19 |
| 2013 | 6 | 18 |
| 2014 | 9 | 16 |
| 2015 | 16 | 25 |
| 2016 | 14 | 37 |
| 2017 | 12 | 19 |
| 2018 | 22 | 18 |
| 2019 | 15 | 31 |
| 2020 | 12 | 28 |
| 2021 | 22 | 32 |
| 2022 | 13 | 32 |
| 2023 | 21 | 33 |
| 2024 | 20 | 39 |
| 2025 | 19 | 31 |
| 2026 | 10 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for inducing immune tolerance8 Sep 2026US 12,728,155 B2Anokion SA
- Polymer nanoparticle composition for inducing immunity and preparation method therefor30 Jun 2026US 12,667,618 B2Samyang Holdings Corporation
- Compositions, devices and methods for inducing immune responses to infectious agents16 Jun 2026US 12,653,888 B2Sigilon Therapeutics, Inc.
- Nucleic acid nanostructure platform for programming immune stimulation2 Jun 2026US 12,642,850 B2Massachusetts Institute of Technology
- Self-assembling nanoparticles2 Jun 2026US 12,642,851 B2Barinthus Biotherapeutics North America, Inc.
- Modified biotin-binding protein, fusion proteins thereof and applications10 Sep 2026US 2026/0265313 A1Children's Medical Center Corporation
- Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response27 Aug 2026US 2026/0248912 A1Barinthus Biotherapeutics North America, Inc.
- Micromolded or 3-d printed pulsatile release vaccine formulations6 Aug 2026US 2026/0224697 A1Massachusetts Institute of Technology
- Mrna, mrna vaccine formulation, and preparation method and use thereof18 Jun 2026US 2026/0166134 A1Panru Biotechnology (Tianjin) Co., Ltd
- Compositions for delivery of plasmodium csp antigens and related methods4 Jun 2026US 2026/0151470 A1BioNTech SE
Most cited
By later US patents
- Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity737US 4,554,101 ANew York Blood Center, Inc. · 1985
- Antigen-carrying microparticles and their use in the indication of humoral or cellular responses118US 5,871,747 AInstitut Pasteur · 1999
- Synthetic vaccine and process for producing same104US 4,474,757 AYeda Research and Development Co. Ltd. · 1984
- Allergen-containing substances87US 4,261,973 APharmacia Corporation · 1981
- Antigen delivery compositions and methods of use85US 7,303,881 B2PDS Biotechnology Corporation · 2007